GlaxoSmithKline Inc. vaccines recall in Canada: potential underdosing
In plain language
This recall involves several GlaxoSmithKline Inc. vaccines sold in Canada. They are being recalled because syringes may leak, which could lead to underdosing and leave patients inadequately protected. Healthcare professionals are advised not to use leaking syringes.
What to do
- Stop using the product immediately.
- Return, repair, or dispose of it as instructed.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Specific affected products are listed in the official notice.
Why this matters
Potential risk of underdosing
Do I have this product?
This recall applies to specific products. Details are listed in the official notice.
Frequently Asked Questions
Why was this product recalled?
Potential risk of underdosing
What should consumers do?
Stop using the product immediately. Return, repair, or dispose of it as instructed.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Potential risk of underdosing
When was this product recalled?
This product was recalled on May 1, 2018.
Is the BOOSTRIX, BOOSTRIX-POLIO, ENGERIX-B, HAVRIX, HAVRIX Junior, INFANRIX-IPV, INFANRIX-IPV/HIB, INFANRIX-hexa, TWINRIX, TWINRIX Junior brand affected by this recall?
Yes, BOOSTRIX, BOOSTRIX-POLIO, ENGERIX-B, HAVRIX, HAVRIX Junior, INFANRIX-IPV, INFANRIX-IPV/HIB, INFANRIX-hexa, TWINRIX, TWINRIX Junior products are affected by this recall. This recall involves several GlaxoSmithKline Inc. vaccines sold in Canada. They are being recalled because syringes may leak, which could lead to underdosing and leave patients inadequately protected. Healthcare professionals are advised not to use leaking syringes.